Mason Street Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-16,200
| Closed | -$969K | – | 915 |
|
|
2020
Q4 | $969K | Buy |
16,200
+164
| +1% | +$9.81K | 0.02% | 950 |
|
|
2020
Q3 | $964K | Buy |
16,036
+223
| +1% | +$13.4K | 0.02% | 833 |
|
|
2020
Q2 | $830K | Buy |
15,813
+1,278
| +9% | +$67.1K | 0.02% | 902 |
|
|
2020
Q1 | $487K | Hold |
14,535
| – | – | 0.01% | 999 |
|
|
2019
Q4 | $658K | Buy |
14,535
+411
| +3% | +$18.6K | 0.01% | 1039 |
|
|
2019
Q3 | $538K | Buy |
+14,124
| New | +$538K | 0.01% | 1078 |
|